Crossmark

Long-term efficacy of the treat-to-close strategy for patients with atrial septal defect-pulmonary artery hypertension and characteristics of indicated populations

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2026.100861

Published Print: 2026-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fan, Jianing https://orcid.org/0000-0002-1952-2701
Long, Yuliang https://orcid.org/0009-0000-8855-1322
Qi, Jin https://orcid.org/0000-0003-3307-3663
Lin, Dawei https://orcid.org/0009-0006-5870-7780
Zhang, Feng https://orcid.org/0000-0002-6790-7673
Zhan, Zhi https://orcid.org/0000-0003-0265-5839
Chen, Dandan https://orcid.org/0000-0001-5825-8918
Pan, Wenzhi https://orcid.org/0000-0002-0530-261X
Guan, Lihua https://orcid.org/0009-0001-7909-7524
Zhou, Daxin https://orcid.org/0009-0007-9814-3630
Ge, Junbo https://orcid.org/0009-0003-3442-4477
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82,200,456)

Shanghai Clinical Research Center

The University of Texas Southwestern Medical School Center for Depression Research and Clinical Care (19MC1910300)
License Information

Text and Data Mining valid from 2026-01-01

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2026-01-30
More Information

This article is maintained by: Elsevier

Article Title: Long-term efficacy of the treat-to-close strategy for patients with atrial septal defect-pulmonary artery hypertension and characteristics of indicated populations

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2026.100861

Content Type: article

Copyright: © 2026 Published by Elsevier España, S.L.U. on behalf of HCFMUSP.

Document is current

Any future updates will be listed below